Monoclonal antibodies. Hybrid myelomas--a revolution in serology and immunogenetics.
Year: 1979
Type: article
Abstract: In 1975 Kohler and Milstein [1] reported an experimental method of obtaining hybrid plasmacytoma cell lines that make antibody against preselected antigens. Their approach was suggested by the. observation that hybrids made by fusing two antibody-producing cells continue to secrete the antibodies originally produced by each of the two parental cell types [2, 3]. They carried this observation one step further and stimulated what may well become a revolution in the fields of serology, immunology, and cell biology. They fused spleen cells, from a mouse immunized against sheep red blood cells, with P3X63Ag8, a plasmacytoma line. As many as 10% of the hybrid clones were found to secrete antibody against sheep red blood cells into the culture medium [1]. The frequency of hybrids making antibody against the recently injected antigen suggested a preferential fusion or hybrid formation with spleen cells recently stimulated by antigen. Kohler, Milstein and co-workers used the same procedure (fig. 1) to produce monoclonal antibodies against the hapten 2,4,6,-Trinitrophenyl, and mouse IgD [4, 5]. They also reported mouse plasmacytoma x rat spleen cell hybrids making antibody against a rat histocompatibility antigen [6] and leukocyte differentiation antigens [7]. It soon became clear that this technique of monoclonal antibody production is useful for producing antibodies against a wide range of antigens. Effectively, what one does in this procedure is to immunize (usually a mouse or rat) with an antigen containing an array of antigenic determinants, allow the animal to respond, and then, use the spleen cells to generate hybrid plasmacytomas. Each hybrid that secretes antibody to the antigen of interest is producing a single clonal component of the animal' s complex antibody response and is thus a so-called monoclonal antibody. Preliminary to the production of hybrids making antibody against a chosen antigen, it is essential that there be available an assay procedure that enables the discrimination
Source: Europe PMC (PubMed Central)
Author: R G Kennett
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W154643472
